» Articles » PMID: 39226188

Nanotechnology-Based Drug Delivery Systems for Treating Acute Kidney Injury

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Acute kidney injury (AKI) is a disease that is characterized by a rapid decline in renal function and has a relatively high incidence in hospitalized patients. Sepsis, renal hypoperfusion, and nephrotoxic drug exposure are the main causes of AKI. The major therapy measures currently include supportive treatment, symptomatic treatment, and kidney transplantation. These methods are supportive treatments, and their results are not satisfactory. Fortunately, many new treatments that markedly improve the AKI therapy efficiency are emerging. These include antioxidant therapy, ferroptosis therapy, anti-inflammatory therapy, autophagy therapy, and antiapoptotic therapy. In addition, the development of nanotechnology has further promoted therapeutic effects on AKI. In this review, we highlight recent advances in the development of nanocarriers for AKI drug delivery. Emphasis has been placed on the latest developments in nanocarrier modification and design. We also summarize the applications of different nanocarriers in AKI treatment. Finally, the advantages and challenges of nanocarrier applications in AKI are summarized, and several nanomedicines that have been approved for clinical trials to treat diverse kidney diseases are listed.

References
1.
Ferguson M, Waikar S . Established and emerging markers of kidney function. Clin Chem. 2012; 58(4):680-9. PMC: 5136473. DOI: 10.1373/clinchem.2011.167494. View

2.
Lopez-Novoa J, Quiros Y, Vicente L, Morales A, Lopez-Hernandez F . New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int. 2010; 79(1):33-45. DOI: 10.1038/ki.2010.337. View

3.
Tu C, Lu H, Zhou T, Zhang W, Deng L, Cao W . Promoting the healing of infected diabetic wound by an anti-bacterial and nano-enzyme-containing hydrogel with inflammation-suppressing, ROS-scavenging, oxygen and nitric oxide-generating properties. Biomaterials. 2022; 286:121597. DOI: 10.1016/j.biomaterials.2022.121597. View

4.
Hu J, Li S, Kang X, Qi J, Wu J, Wang X . CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage. Carbohydr Polym. 2018; 193:268-280. DOI: 10.1016/j.carbpol.2018.04.011. View

5.
Yan J, Wang Y, Zhang J, Liu X, Yu L, He Z . Rapidly Blocking the Calcium Overload/ROS Production Feedback Loop to Alleviate Acute Kidney Injury via Microenvironment-Responsive BAPTA-AM/BAC Co-Delivery Nanosystem. Small. 2023; 19(17):e2206936. DOI: 10.1002/smll.202206936. View